Rivus Pharmaceuticals
Charlottesville
About Rivus Pharmaceuticals
Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health. Rivus Pharmaceuticals is dedicated to improving cardio-metabolic health by developing controlled metabolic accelerators (CMAs) that address the underlying metabolic risk factors for cardiovascular mortality and morbidity.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $290.0M
- Last round: Series Unknown (Jan 2025)
- Website: rivuspharma.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/rivus-pharmaceuticals-6689 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.